C. Scaranna

ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide

G. Veronesi, A. Bossi, G. Lepore, 2020, Diabetes Therapy.

Dapagliflozin acutely improves Kidney Function in Type 2 Diabetes Mellitus. The PRECARE Study.

C. Gazzaruso, P. Fiorina, F. Folli, 2022, Pharmacological research.

Switching from suspend-before-low insulin pump technology to a hybrid closed loop system improves glucose control and reduces glucose variability: a retrospective observational case-control study.

A. Corsi, R. Trevisan, A. Dodesini, 2020, Diabetes technology & therapeutics.

Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes - The TOSCA.IT study.

M. Boemi, E. Bonora, V. Krogh, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.

M. Boemi, E. Bonora, A. Gnasso, 2017, The lancet. Diabetes & endocrinology.

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

J. Bonventre, G. Zuccotti, R. Abdi, 2020, Diabetes Care.

Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control

R. Trevisan, A. Dodesini, G. Lepore, 2022, Acta Diabetologica.

Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.

R. Trevisan, A. Dodesini, G Lepore, 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.